Skip to main content

KRAS G12C Mutation: An Emerging Biomarker for NSCLC

Date: Monday, Jan 4, 2021

Description: Presented by Yuri Fesko, MD and Kari Hooper, MD.


Fesko, Yuri, MD
Chief Clinical Officer, Oncology Quest Diagnostics
Secaucus, New Jersey

Hooper, Kari, MD
Pathologist, AmeriPath®/Quest Diagnostics; Department Chair,
Integris Baptist Medical Center Oklahoma City, Oklahoma